At higher concentrations, C5a accelerates tumor progression by promoting an immunosuppressive microenvironment, inducing angiogenesis, and/or increasing the motility of cancer cells (Corrales et al, 2012; Kolev & Markiewski, 2018; Magrini et al, 2022). The gene discussed is C5AR1; the disease is neoplasm.